Dorvdaiprone Exhibits Durability in H3 K27M-Mutated Diffuse Midline Glioma
Written by
Cancer Network
Published
0
comments
0
min
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.